Biological evaluation of Syzygium aromaticum (L.) Merr. & L.M.Perry against several cancer cell lines
N | Parts of the plant | Solvents | Concentration | Type of cancer | Major finding | Reference |
---|---|---|---|---|---|---|
1 | Unopened flower bud | Aqueous | 100 μL/mouse per day from the fifth week | Lung | In these BP-induced lung lesions, clove therapy significantly decreased the number of proliferative cells and increased the number of apoptotic cells. | [42] |
2 | Bud | Aqueous, ethanol, essential oil | - | Breast | Essential oil had a median lethal dose (LD50) of 37.36 μg/mL and 36.43 μg/mL in the 24-h brine shrimp lethality test (BSLT) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assays, respectively. | [2] |
3 | Bud | Aqueous, ethanol, essential oil | - | Cervical, breast, prostate, esophageal | Within 24 h, oil at 300 μL/mL induced 80% cell death in an esophageal cancer cell line through apoptotic cell death, while prostate cancer cells displayed negligible cell death. | [15] |
4 | Leaves, stem, bark | Methanol | - | Breast | The stem extract exhibits a strong and focused cytotoxic impact on MCF-7 cells, with an IC50 of 33 μg/mL. | [43] |
5 | Eugenol | - | 0.1, 0.2, 0.5, 1, 2, 4, and 8 ng/mL | Cervical | Apoptosis was detected by the IC50 at 81.85% cell viability. | [44] |
6 | Eugenol | - | 1,200, 600, 300, 150, and 75 μg/mL | Breast, skin | The IC50s of chitosan nanoparticles containing Syzygium aromaticum essential oil (SAEO) and eugenol against melanoma (A-375) cells were 73 μg/mL and 79 μg/mL, respectively; for breast (MDA-MB-468) cells, the values were 177 μg/mL and 51 μg/mL. | [45] |
7 | Flower buds | Chloroform | - | Lung | Compared to the control group, the extract fractions inhibited wound closure/cell migration in A549 and H1299 and caused apoptosis in H1299. Nuclei of fraction-treated cells showed signs of apoptosis, including chromatin compression, nuclear shrinkage, and the development of apoptotic bodies. | [46] |
8 | - | - | 2, 3, and 4 mg/mL | Cervical | The extract was tested on HeLa cells and found to have an LD50 of 2 mg/mL after being exposed to the cells for 24 h. In comparison to untreated control cells, treated cells were rounded off with a distinctive death symptom. | [47] |
9 | Eugenol | - | 0, 50, 100, and 200 μmol/L | - | Exhibited cytotoxicity in the HeLa cell line at concentrations between 50 μmol/L and 200 μmol/L. | [48] |
10 | - | Ethanol | 1.25, 12.5, 50, 75, and 100 μg/mL | - | When cancer cells were treated with fluorescent magnetic submicronic polymer (FMSP)-nanoparticles alone, their viability dropped to 55.40%, and when crude clove extracts were additionally added to the treatment, viability dropped to 8.50%. | [49] |
11 | Bud | - | 125, 62.5, 32, and 15 μg/mL | Colon | The IC50 value for Syzygium aromaticum bud essential oil nanoemulsion (SABE-NE) after 48 h was determined to be 74.8 μg/mL. | [50] |
12 | Bud | Ethanol | 0–1,000 μg/mL | Breast | The IC50 values for the extract and nanoparticles were determined to be 20 μg/mL and 7 μg/mL, respectively, in an in vitro assay. | [51] |
13 | - | Essential oil | 0, 30, 60, and 120 μg/mL | Cervical | By significantly decreasing HeLa cell viability at 24-h and 48-h at P-value < 0.0001, the essential oils demonstrated substantial antiproliferative activity. By 48 h, almost no cancer cells had survived at the maximal dose of 120 μg/mL, which not only inhibited proliferation but also drastically reduced the number of HeLa cells. | [52] |
14 | Buds | Aqueous | 10–100 mg/mL | Lung, breast | Phyto-mediated AgNPs had an IC50 of 60 μg/mL against MCF-7 and 50 μg/mL against A549 cells. The extract having IC50 was also found to be 70 μg/mL against MCF-7 and 70 μg/mL against A549 cells. | [53] |
15 | Essential oil | - | 1.25–20% | Breast, leukemia, cervical | When tested on Hela, MCF-7, and K-562 cell lines, 20% essential oil showed the highest percentage of inhibition, 32.8%, 53.5%, and 76.4%, respectively. | [54] |
16 | Buds | Methanol, aqueous | - | Breast, colon, liver | According to the data, the IC50 values were as follows: 31 μg/mL for colon cancer protection against breast cancer, 29.7 μg/mL and 18.7 μg/mL against liver cancer | [55] |
17 | Bud | 70% ethanol | - | Ovarian | Substantial inhibitory effect against human ovarian cancer cells (A2780; IC50 value = 22.67 μmol/L). | [56] |
18 | Buds | Acetonic, dichloromethane, ethanolic, petroleum ether | - | Colon carcinoma | The ethanolic extract of clove was the most effective against the HCT cell line, with an IC50 of 2.53 μg/mL. | [26] |
19 | Essential oil | - | 0.39, 0.781, 1.562, 3.125, 6.25, 12.5, 25, 50, 100, and 200 mg/mL | Colon | At 3.25 mg/mL of SAEO, the maximum cell vitality was recorded, whereas increasing the concentration of the essential oil to 200 mg/mL resulted in relatively low cell viability. | [57] |
20 | Buds | Methanol | - | Cervix, breast, lung | When cell death is tested on HeLa cells, the median lethal concentration (LC50) was 88 ± 3.4 μg/mL, whereas on MCF-7 cells, it was 86 ± 2.8 μg/mL. | [58] |
21 | Leaves, buds, flower | 50% ethanol | 6.25, 12.5, 25, 50, 100, 200, and 400 μg/mL | Breast | The IC50 values for cytotoxicity against Hela and MDA-MB-231 cell lines were 40 μg/mL and 48 μg/mL, whereas those for flower buds and young flower buds were 35 μg/mL and 39 μg/mL. | [59] |
22 | - | - | - | - | The relative IC50 value of the ethanolic clove extract was 6.8 μg/mL, making it the most potent antiproliferative agent tested. | [60] |
23 | - | - | - | Breast | The accumulation of nanoparticles in the sub-G1 phase of the cell cycle after treatment with extract coated with polyvinylpyrrolidone (PVP) iron oxide nanoparticles and PVP iron oxide nanoparticles in MCF-7 cell lines confirmed the induction of apoptosis. | [61] |
24 | Flower buds | Ethanolic | - | Cervical | Cell viability was found to decrease after treatment with the extract in a dose- and time-dependent manner, suggesting an antiproliferative action (P < 0.05). | [62] |
25 | Flower | Aqueous | 50–1,000 ppm | - | LC50 values of 227.1 g/mL showed that the extract is toxic to larvae. | [63] |
-: not applicable